← All companies
BIOCRYST PHARMACEUTICALS INC
BCRX - CIK 0000882796
Market cap$2.08 B
Rank#2072
SEC filings1,935
The table below shows BIOCRYST PHARMACEUTICALS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $89.74M | $104.71M | $110.64M | $304.77M | $504.39M | $272.13M |
| Short-term investments | $185.01M | - | - | - | - | - |
| Receivables | $106.82M | $79.07M | $56.95M | $50.60M | $29.41M | $8.65M |
| Inventory | $5.40M | $31.27M | $28.68M | $27.53M | $15.79M | $7.04M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.